Skip to content

Clinical trials

Not yet recruiting Anemia, Refractory, with Excess of Blasts trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Refractory, with Excess of Blasts Status: Not yet recruiting Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Not yet recruiting6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ARCE Therapeutics, Inc.1
Miltenyi Biomedicine GmbH1
Ossium Health, Inc.1
Technische Universität Dresden1
University Hospital Tuebingen1
University Hospital, Grenoble1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Refractory, with Excess of Blasts6
Leukemia, Myeloid, Acute4
Hematologic Diseases1
Hematologic Neoplasms1
Hodgkin Disease1
Leukemia1
Leukemia, B-Cell1
Leukemia, Biphenotypic, Acute1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive1
Lymphoma1

Trials

Showing 26 to 6 of 6. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.